Small Molecule Targeting of PAI-1 Function: A New Therapeutic Approach for Treatment of Vascular Stenosis
- PMID: 24382978
- PMCID: PMC3875289
- DOI: 10.4172/1747-0862.1000059
Small Molecule Targeting of PAI-1 Function: A New Therapeutic Approach for Treatment of Vascular Stenosis
Figures
References
-
- Wu K, Urano T, Ihara H, Takada Y, Fujie M, et al. The cleavage and inactivation of plasminogen activator inhibitor type 1 by neutrophil elastase: the evaluation of its physiologic relevance in fibrinolysis. Blood. 1995;86:1056–1061. - PubMed
-
- Otsuka G, Agah R, Frutkin AD, Wight TN, Dichek DA. Transforming growth factor β1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways. Arterioscler Thromb Vasc Biol. 2006;26:737–743. - PubMed
-
- Otsuka G, Stempien-Otero A, Frutkin AD, Dichek DA. Mechanisms of TGF-beta1-induced intimal growth: plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cells. Circ Res. 2007;100:1300–1307. - PubMed
-
- Declerck PJ, De Mol M, Vaughan DE, Collen D. Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator. J Biol Chem. 1992;267:11693–11696. - PubMed
-
- Urano T, Strandberg L, Johansson LB, Ny T. A substrate-like form of plasminogen-activator-inhibitor type 1. Conversions between different forms by sodium dodecyl sulphate. Eur J Biochem. 1992;209:985–992. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous